⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18291441 | 1.00 | — | — | |
| SCHEMBL7517602 | 0.76 | — | — | |
| SCHEMBL3159028 | 0.74 | LMNA (0.32) | — | |
| SCHEMBL28632794 | 0.74 | — | — | |
| SCHEMBL31296254 | 0.74 | THRB (0.50) | — | |
| SCHEMBL19711171 | 0.74 | — | — | |
| SCHEMBL27730330 | 0.73 | — | — | |
| SCHEMBL14434966 | 0.73 | — | — | |
| SCHEMBL16742365 | 0.72 | ALDH1A1 (0.36) | — | |
| SCHEMBL2094168 | 0.69 | LMNA (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0955291-B1 | Preparation of 2-substituted pyridines | DOW AGROSCIENCES LLC (US) | 2002-07-10 | — | — | EP | claimed |
| US-6054583-A | Preparation of 2-substituted pyridines | ROHM AND HAAS COMPANY (US) | 2000-04-25 | — | — | US | claimed |
| EP-0955291-A1 | Preparation of 2-substituted pyridines | ROHM AND HAAS COMPANY (US) | 1999-11-10 | — | — | EP | claimed |
| EP-0826739-A1 | Process for the preparation of substituted aminoanthraquinones | BAYER AG (DE) | 1998-03-04 | — | — | EP | claimed |
| US-12037355-B2 | Triterpene saponin analogues | ADJUVANCE TECHNOLOGIES, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2024148274-A1 | COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024147060-A1 | NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY | CELON PHARMA S.A. (PL) | 2024-07-11 | — | — | WO | disclosed |
| EP-4396354-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | Wave Life Sciences Ltd. (SG) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024145435-A2 | LIPID COMPOSITIONS AND METHODS FOR DELIVERY TO IMMUNE CELLS | Life Technologies Corporation (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024140431-A1 | COMPOUNDS COMPRISING HETEROARYL RINGS AND COMPOSITIONS AND METHODS THEREOF | IONGEN THERAPEUTICS CO., LTD. (CN) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024130217-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024130218-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| US-5594006-A | SUCH AS COLLEGENASE, STROMELYSIN; ANTICANCER AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-01-14 | — | — | US | disclosed |
| WO-1996026933-A1 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | GILEAD SCIENCES, INC. (US) | 1996-09-06 | — | — | WO | disclosed |
| WO-1996023801-A2 | NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME | GILEAD SCIENCES, INC. (US) | 1996-08-08 | — | — | WO | disclosed |
| WO-1996014314-A2 | THIEPANE COMPOUNDS INHIBITING AND DETECTING HIV PROTEASE | GILEAD SCIENCES, INC. (US) | 1996-05-17 | — | — | WO | disclosed |
| EP-0368750-B1 | Process for preparing substituted aminoanthraquinones | SUMITOMO CHEMICAL CO (JP) | 1994-10-26 | — | — | EP | disclosed |
| US-5017713-A | Alkylation | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| EP-0368750-A2 | Process for preparing substituted aminoanthraquinones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-05-16 | — | — | EP | disclosed |
| US-4560447-A | Electrolytic process for preparation of α-alkylated acetic acid derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1985-12-24 | — | — | US | disclosed |